Economic aspects of pneumococcal pneumonia: a review of the literature

PharmacoEconomics
D de Graeve, Philippe Beutels

Abstract

In this review, the economic aspects of pneumococcal pneumonia are analysed, including the costs, cost effectiveness and cost benefit of treatment and prevention. We identified eight cost-of-illness studies, 15 analyses comparing the costs of different treatment options and 15 economic evaluations of prevention that met our search criteria. The studies were conducted largely in Europe and the US. Most pertained to community-acquired pneumonia (CAP) in general, without specific analysis of pneumococcus-related illness. Many of the studies were considered to be of poor quality for the following reasons: comparison without randomisation or control variables, disregard of health outcomes, small sample size, restriction of costs to drug costs and vague or disputable sources of cost information. In the US, hospitalisation costs resulting from CAP can be estimated to be between US 7,000 dollars and US 8,000 dollars per admission or US 4 million dollars per 100,000 population. Hospitalisation costs are significant (representing about 90% of total costs), but are much lower in Europe than in the US (one-third to one-ninth of the US estimates in the UK and Spain, respectively). In general, economic studies of treatment for pneumococcal p...Continue Reading

References

Jun 15, 1996·BMJ : British Medical Journal·S K ObaroD C Henderson
Jul 1, 1996·Journal of General Internal Medicine·J R LaveW N Kapoor
Jul 1, 1997·The European Respiratory Journal·J F Guest, A Morris
Oct 29, 1997·JAMA : the Journal of the American Medical Association·J E SiskJ C Butler
Sep 16, 1998·Clinical Therapeutics·M S NiedermanR Popovian
Oct 28, 1998·Scandinavian Journal of Infectious Diseases·S EinarssonS Jonsson
Sep 9, 1999·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·K B HowardR P Rapp
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P Vold Pepper, D K Owens
Mar 25, 2000·JAMA : the Journal of the American Medical Association·T A LieuH R Shinefield
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A AmentD S Fedson
Jan 9, 2001·Archives of Internal Medicine·M WeaverS Ciske
Feb 15, 2001·The New England Journal of Medicine·J EskolaUNKNOWN Finnish Otitis Media Study Group
Jun 13, 2001·American Journal of Respiratory and Critical Care Medicine·M S NiedermanUNKNOWN American Thoracic Society
Dec 12, 2001·The Pediatric Infectious Disease Journal·S B BlackF Malinoski
Jan 5, 2002·European Journal of Public Health·V MongeA González
Mar 19, 2002·American Journal of Respiratory and Critical Care Medicine·Vladimir KaplanWalter T Linde-Zwirble
Aug 2, 2002·The Pediatric Infectious Disease Journal·G Thomas RayTracy A Lieu
Jan 25, 2003·The Pediatric Infectious Disease Journal·Bruce FiremanPaula Ray
May 2, 2003·The New England Journal of Medicine·Cynthia G WhitneyUNKNOWN Active Bacterial Core Surveillance of the Emerging Infections Program Network
May 2, 2003·The New England Journal of Medicine·Lisa A JacksonUNKNOWN Vaccine Safety Datalink
Oct 1, 2001·Expert Review of Pharmacoeconomics & Outcomes Research·P Beutels, M J Postma

❮ Previous
Next ❯

Citations

Feb 1, 2011·Drugs·Charles Feldman, Ronald Anderson
Jan 31, 2009·Srpski arhiv za celokupno lekarstvo·Tatjana AdzićSnezana Medić-Stojanac
Dec 21, 2013·Brain : a Journal of Neurology·Nicolas T LindauMartin E Schwab
Apr 26, 2006·Expert Opinion on Pharmacotherapy·Liangsu Wang, John F Barrett
Jun 19, 2010·International Journal of Antimicrobial Agents·Ronald N JonesHelio S Sader
Jul 17, 2007·Vaccine·Michael DrummondMickael Lothgren
Dec 10, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J J C Drijkoningen, G G U Rohde
Jun 6, 2007·Respiratory Medicine·Hartmut M Lode
Jun 4, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Donald B MiddletonDwight E Fox
Feb 14, 2019·Expert Review of Vaccines·Andrew D WieseCarlos G Grijalva
Jul 20, 2006·Journal of Medical Microbiology·Stuart C Clarke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.